Tanya Wildes MD Profile picture
Heme/onc/geriatrician @UNMC @NebraskaMedicine studying Myeloma & other cancers + Aging. Training for Peru Trek: https://t.co/wI3oswKkxL

Dec 8, 2019, 6 tweets

Blown away by rising star @mwschoen's masterful storytelling of how he is trying to understand and eradicate racial disparities in myeloma treatment and outcomes...
file:///var/folders/mw/0w9f93f97wscrp764dmz0k900000gp/T/com.apple.iChat/Messages/Transfers/IMG_6462.jpeg #ASH19

@mwschoen Dr. Schoen walks us through a hypothesis that renal impairment and racial differences in estimating renal function may impact treatment and outcome: 1) Pts with renal dies less likely to receive lenalidomide.

@mwschoen 2) Black veterans have higher creatinine but better GFR... if clinician only looks at creatinine, may err in understanding pts renal function.

@mwschoen 3) Black patients more likely to be coded as having renal disease by ICD9 codes

@mwschoen 4) Black pts less likely to receive lenalidomide

@mwschoen 5) Summary - results lead to hypothesis that higher rates of diagnosis of renal disease based on erroneous interpretation of Creatinine in black patients may mediate racial disparities in treatment

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling